Allotment is out. Check your result on the Gaudium IVF IPO Allotment Status page.
Gaudium IVF IPO logo

Gaudium IVF IPO Subscription

Listed

Updated 27 February 2026, 9:15 AM IST· Mainboard

Gaudium IVF IPO subscription closed on 24 February 2026 at 7.27x overall by shares. QIB demand came in at 1.62x, NII at 14.05x, and retail at 7.60x. See Retail, SHNI, and BHNI allotment chances in the table below.

Allotment date is 25 February 2026. Listing date on NSE and BSE is 27 February 2026.

Issue Price
Rs 79.00
GMP Today
-
Overall Sub
7.27x
Issue Size
₹165.00 Cr
Allotment
25 Feb 2026
Listing
27 Feb 2026

Gaudium IVF IPO Day-wise Subscription

Daily QIB, NII, Retail, and overall subscription as bids come in

DayQIBNIIRetailOverall
Day 1 - 20 Feb 20260.00x0.91x1.42x0.90x
Day 2 - 23 Feb 20260.02x4.64x4.06x3.03x
Day 3 - 24 Feb 20261.62x14.05x7.60x7.27x

Gaudium IVF IPO Allotment Chances

Retail, SHNI, and BHNI chances based on application subscription

Gaudium IVF IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.

CategorySubscription (Apps)Allotment Chances
Retail6.22x1 in 6
SHNI (Rs 2L to Rs 10L)15.94x1 in 16
BHNI (above Rs 10L)2.52x1 in 3

Chances use application subscription (how many bids came in), not share or amount figures. If you get allotment, you get at least one lot. Higher subscription means lower chance per PAN.

Check the Gaudium IVF IPO Allotment Status page from 25 February 2026 for your result.

Gaudium IVF IPO Subscription by Amount

Category-wise subscription based on amount applied at issue price Rs 79.00

CategoryAmount OfferedAmount AppliedSubscription
QIBRs 33.00 CrRs 53.61 Cr1.62x
FII-Rs 25.46 Cr-
DFI-Rs 72.27 L-
Mutual Funds---
Other-Rs 27.42 Cr-
NIIRs 24.75 CrRs 347.77 Cr14.05x
bNII (above Rs 10L)Rs 16.50 CrRs 209.79 Cr12.71x
Corporate-Rs 3.65 Cr-
Individual-Rs 195.56 Cr-
Other-Rs 10.58 Cr-
sNII (Rs 2L to Rs 10L)Rs 8.25 CrRs 137.98 Cr16.73x
Corporate-Rs 75.55 L-
Individual-Rs 131.90 Cr-
Other-Rs 5.33 Cr-
RetailRs 57.75 CrRs 438.79 Cr7.60x
Cut-off price-Rs 371.24 Cr-
Fixed price-Rs 67.55 Cr-
TotalRs 115.50 CrRs 840.17 Cr7.27x

Gaudium IVF IPO Subscription by Applications

Category-wise subscription based on applications received

CategoryApplications OfferedApplications ReceivedSubscription
QIB41,77,240380.00x
FII-15-
DFI-2-
Mutual Funds---
Other-21-
NII1,1848,2867.00x
bNII (above Rs 10L)7891,9902.52x
Corporate-13-
Individual-1,891-
Other-86-
sNII (Rs 2L to Rs 10L)3956,29615.94x
Corporate-34-
Individual-6,013-
Other-249-
Retail38,6782,40,6916.22x
Cut-off price-2,03,908-
Fixed price-36,783-
Total42,17,1022,49,0150.06x

What Do These Subscription Numbers Mean?

7.27x overall by shares means bids covered about 7 times the shares on offer. Allotment chances depend on applications in each category.

QIB at 1.62x by shares shows institutional demand from mutual funds, FIIs, and banks.

NII covers bids above Rs 2 lakh (7.00x by applications). Split: SHNI 15.94x, BHNI 2.52x by applications. SHNI and BHNI allotment is by lottery.

At 6.22x subscription by applications, about 1 in 6 retail applicants may get allotment (~16% chance per application). Retail allotment is also by lottery.

Gaudium IVF IPO Key Dates

EventDate
IPO Open Date20 February 2026
IPO Close Date24 February 2026
Allotment Date25 February 2026
Refund Initiation26 February 2026
Share Credit to Demat26 February 2026
Listing Date27 February 2026
Minimum InvestmentRs 14,931.00
Lot Size189 shares

About Gaudium IVF IPO

Gaudium IVF & Women Health Ltd. is a leading fertility care provider in India specializing in In Vitro Fertilization (IVF) and assisted reproductive technologies (ART). Operating through a hub-and-spoke model with 7 hubs and 28 spokes, the company provides high-end fertility treatments and gynecological care.

Understanding Subscription Categories

QIB - Qualified Institutional Buyers

Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.

NII - Non-Institutional Investors (SHNI & BHNI)

Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.

Retail - Retail Individual Investors

Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.

Advertisement

Gaudium IVF IPO Subscription FAQs

What is Gaudium IVF IPO subscription status today?

Gaudium IVF IPO subscription closed on 24 February 2026 with overall subscription of 7.27x (by shares) as of 19 August 2026, 4:17 AM IST. QIB 1.62x, NII 7.00x, Retail 6.22x.

What is the overall subscription of Gaudium IVF IPO?

Gaudium IVF IPO is subscribed 7.27x overall by shares at close on 24 February 2026. QIB 1.62x, NII 7.00x, and Retail 6.22x.

What is Gaudium IVF IPO QIB subscription?

Gaudium IVF IPO QIB (Qualified Institutional Buyers) subscription is 1.62x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.

What is Gaudium IVF IPO Retail subscription?

Gaudium IVF IPO Retail subscription is 6.22x by applications. Retail bids are up to Rs 2 lakh per PAN.

What is Gaudium IVF IPO NII, SHNI, and BHNI subscription?

Gaudium IVF IPO NII subscription is 7.00x by applications. NII is bids above Rs 2 lakh, split into SHNI (Rs 2L to Rs 10L) at 15.94x and BHNI (above Rs 10L) at 2.52x.

What are Gaudium IVF IPO retail allotment chances?

At 6.22x subscription by applications, about 1 in 6 retail applicants may get allotment (~16% chance per application). Allotment is by lottery. Share subscription was 7.60x. Allotment chances use applications, not share volume.

What are Gaudium IVF IPO SHNI allotment chances?

At 15.94x subscription by applications, about 1 in 16 SHNI applicants may get allotment (~6% chance per application). Allotment is by lottery. Share subscription was 16.73x. Allotment chances use applications, not share volume.

What are Gaudium IVF IPO BHNI allotment chances?

At 2.52x subscription by applications, about 1 in 3 BHNI applicants may get allotment (~40% chance per application). Allotment is by lottery. Share subscription was 12.71x. Allotment chances use applications, not share volume.

When is Gaudium IVF IPO allotment date?

Gaudium IVF IPO allotment date is 25 February 2026. Check Gaudium IVF IPO Allotment Status on IPOwiz from that day using your PAN.

When does Gaudium IVF IPO subscription close?

Gaudium IVF IPO subscription closed on 24 February 2026. No new applications are accepted after the close.

What is Gaudium IVF IPO GMP today?

GMP for Gaudium IVF IPO is not available yet. Track Gaudium IVF IPO GMP Today on IPOwiz once grey market activity starts.

What is Gaudium IVF IPO issue price and lot size?

Gaudium IVF IPO issue price is ₹79 per share. Lot size is 189 shares. Minimum investment is ₹14,931 per lot. Issue size: ₹165.00 Cr.

When is Gaudium IVF IPO listing date?

Gaudium IVF IPO listing date is 27 February 2026 on NSE and BSE. Allotment is on 25 February 2026.

How does subscription affect Gaudium IVF IPO allotment?

In Gaudium IVF IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At 7.27x overall, competition is moderate.

For allotment results from 25 February 2026, visit the Gaudium IVF IPO Allotment Status page. For listing day updates on 27 February 2026, download the IPOwiz App.

Sources

We match Gaudium IVF IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.

  • SEBIRules for IPO allotment and disclosures in India
  • NSEExchange notices, bidding data, and listing updates
  • BSEExchange notices and IPO allotment check tools
  • RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
  • IPO RegistrarRegistrar details are on the allotment page for this IPO

Also read our Editorial Policy, How GMP is calculated, and How allotment chances work.

Reviewed by

Dinesh Agrawal · Lead IPO Analyst

15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.